Overview
Peter Hongdau Liu, MD, PhD, is an attending surgeon at Montefiore Einstein and Assistant Professor, Surgical Oncology at Albert Einstein College of Medicine. Dr. Liu’s clinical focus includes malignant and benign diseases of the pancreas, liver, gallbladder, small bowel and stomach, as well as endocrine diseases, specifically thyroid, parathyroid and adrenal endocrinopathies.
After obtaining his Bachelor of Science in biology from the California Institute of Technology in 2009, Dr. Liu attended the Icahn School of Medicine at Mount Sinai where he earned both his Doctor of Medicine and his Doctor of Philosophy in cancer biology in 2018. He then completed his general surgery residency at Mount Sinai Hospital in 2023, where he served as Chief Education Resident. Following this, Dr. Liu completed a complex general surgical oncology fellowship at the University of Miami in 2025.
Dr. Liu’s research has focused on drug discovery for novel radiosensitizers in TP53-mutant tumors. His current scientific interests include cancer genetics, tumor immunology, and genetic predictors of treatment response. He is also actively involved in surgical education and disparities in healthcare access. He has shared his work through numerous peer-reviewed publications as well as abstracts and poster presentations at national and international conferences.
His clinical expertise encompasses Cholangiocarcinoma (Bile Duct Cancer), Pancreatic Cancer, Stomach Cancer, Pancreaticoduodenectomy, and Hepato-Pancreato-Biliary Surgery.
Dr. Liu is board certified in American Board Of Surgery. He is actively involved in clinical research, co-authoring 1 peer reviewed article.
Residency
Specialties
Licenses
Board Certifications
Fellowships
Hospital Affiliations
Languages Spoken
Gender
Awards
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- MEDICARE SNP
- EPO
- HMO
- POS
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- OTHER COMMERCIAL
- OTHER MEDICARE
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- EPO
- HMO
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- OTHER COMMERCIAL
- OTHER MEDICARE PART D
- MANAGED MEDICAID PLAN
- MEDICARE SNP
- HMO
- POS
- HMO
- INDEMNITY
- POS
- PPO
- MEDICARE SNP
- OTHER MANAGED MEDICAID
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE-MEDICAID PLAN
- EPO
- PPO
- EPO
- HMO
- PPO
- MEDICARE-MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE-MEDICAID PLAN
- EPO
- HMO
- POS
- PPO
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
1575 Blondell Ave, Suite 200, The Bronx, NY 10461
Additional Areas of Focus
Dr. Liu has provided the following conditions as areas of focus. Please note that we may not have enough data to validate their experience in some of these conditions.
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Rockefeller Outpatient Pavilion
Samuel Singer is a Surgical Oncologist practicing medicine in New York, New York. He has been practicing medicine for over 44 years. Dr. Singer is highly rated in 28 conditions, according to our data. His clinical expertise encompasses Liposarcoma, Undifferentiated Pleomorphic Sarcoma, Adult Soft Tissue Sarcoma, Reconstructive Urology Surgery, and Nephrectomy. Dr. Singer is currently accepting new patients.
Northwell Health Physician Partners Surgical Oncology At Lake Success
"Matthew J. Weiss, MD, FACS, is deputy physician-in-chief and director of the surgical oncology program at Northwell Cancer Institute. He's a board-certified surgeon specializing in pancreas and liver diseases.With a relentless work ethic and strong desire to help people, Dr. Weiss always knew he wanted to be a doctor. ""I picked a field that allows me to tackle difficult problems and truly make an impact,"" he says.Dr. Weiss completed his residency in general surgery at Johns Hopkins Hospital and was dual fellowship trained in surgical oncology and hepatobiliary surgery at Memorial Sloan-Kettering Cancer Center. He was previously chief of hepatobiliary surgery at Johns Hopkins, where he was also director of the Pancreas and Liver Multidisciplinary Clinics and the complex general surgical oncology fellowship. He also performed the first robotic Whipple at Johns Hopkins University. Joining Northwell in 2019, Dr. Weiss created a multidisciplinary team of surgeons, medical and radiation oncologists, geneticists, and other specialists who collaborate to create unique treatment plans for patients across the health system. ""Every cancer is different, and every patient is different,"" he says. ""Communication among multiple providers is the best way to ensure you're treating the entire person, properly,"" he says. Dr. Weiss's team also works with scientists from Cold Spring Harbor Laboratory and Feinstein Institutes for Medical Research to develop and run groundbreaking clinical trials. An international leader in both liver and pancreas surgery, Dr. Weiss has authored over 250 peer-reviewed publications in the field, and he's currently a professor of surgery and oncology at the Donald and Barbara Zucker School of Medicine at Hofstra/Northwell. ""Understanding both the science of the disease and the technological aspect of surgery is so important,"" he says. Dr. Weiss focuses on using cancer genetics to help find the right surgical approach for patients. When possible, he operates robotically using small incisions for faster healing, so patients don't have to wait as long to receive additional therapies that can improve outcomes. With recent advancements in the field, Dr. Weiss has been able to successfully perform high-risk surgeries that were turned down by other institutions. ""Being a surgeon is a tremendous responsibility, and I don't take it lightly,"" he says. ""I truly and deeply care about my patients and their families-I get to know them as people and am there throughout their entire journey. That's what I'm most proud of as a doctor.""". Dr. Weiss is highly rated in 20 conditions, according to our data. His clinical expertise encompasses Pancreatic Cancer, Cholangiocarcinoma (Bile Duct Cancer), Pancreatic Ductal Adenocarcinoma, Pancreatectomy, and Hepatectomy. Dr. Weiss is board certified in American Board Of Surgery. Dr. Weiss is currently accepting new patients.
Rockefeller Outpatient Pavilion
Daniel Coit is a Surgical Oncologist practicing medicine in New York, New York. Dr. Coit is highly rated in 25 conditions, according to our data. His clinical expertise encompasses Stomach Cancer, Melanoma, Merkel Cell Carcinoma, Pancreaticoduodenectomy, and Lymphadenectomy. Dr. Coit is currently accepting new patients.
Frequently Asked Questions about Dr. Hongdau P. Liu
How do I make an appointment with Dr. Hongdau P. Liu?
You can book an appointment with Dr. Hongdau P. Liu by calling their office at 718-920-4800. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.
Is Dr. Hongdau P. Liu a top-rated expert for Pancreaticoduodenectomy?
MediFind is an objective health platform that identifies experts based on real-world data. Dr. Hongdau P. Liu is classified as an Experienced expert for Pancreaticoduodenectomy, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
What conditions does Dr. Hongdau P. Liu specialize in?
While Dr. Hongdau P. Liu is a Surgical Oncology, they have specific expertise in Pancreaticoduodenectomy, Cholangiocarcinoma (Bile Duct Cancer), and Pancreatic Cancer. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Surgical Oncology.
Does Dr. Hongdau P. Liu participate in research or clinical trials?
Yes. Dr. Hongdau P. Liu has published 1 articles and abstracts on conditions like Pancreaticoduodenectomy. You can view a list of Dr. Hongdau P. Liu's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Does Dr. Hongdau P. Liu accept my insurance?
Dr. Hongdau P. Liu accepts most major insurance plans, including Aetna and Anthem BCBS. We recommend calling the office directly at 718-920-4800 to verify that your specific plan is currently accepted before your visit.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers